HRCI-HRB Joint Funding Scheme 2022 (previously MRCG-HRB) (Next call TBC)

This innovative joint funding scheme allows members of HRCI to support research addressing their research strategy, where they might otherwise not be in a position to finance the full cost of that research. To date, 134 projects have been jointly funded by member charities and the HRB in ten rounds. While no differentiation is made between charities or disease areas, the scheme has been particularly beneficial for rare diseases where research being undertaken internationally may be limited and where charities wishing to contribute to the research agenda need to fund research projects led from outside Ireland.

Additional Information

The HRCI/HRB Joint Funding Scheme enables HRCI-registered research charities to support research of particular interest to specific patient populations. The scheme provides funding for research projects in disease areas that are of strategic relevance to individual HRCI-registered research charities.

Each HRCI/HRB Joint Funding Scheme award is worth up to €300,000 for a project of between 12 and 36 months’ duration. The award scheme may involve the co-funding of a single project by up to four Irish HRCI charities, or by one Irish HRCI charity and one international charity.

Both the HRB and HRCI wish to promote the active involvement of members of the public in the research areas that we fund. Therefore, we encourage public participation within the co-applicant and/or collaborator team (e.g. community groups, non-governmental organisations (NGOs), patient groups).

Participating charities will open calls for proposals through their respective websites/communications channels. Researchers who are interested in applying for this scheme should contact HRCI for further information.


Lead Applicants should be at mid-stage or senior stage in their career.

The research team should have the necessary breadth and depth of expertise in each of the methodological areas required for the proposed project. Typically, applicants are located in the Republic of Ireland. It is possible to fund researchers who are working in host institutions not located in the Republic of Ireland if there is no established research capacity in Ireland, e.g. for the investigation of a particular rare disease.


All applications must be made to the HRCI-registered research charity on or before its defined closing date (contact the relevant charity for their internal deadlines).

The application must have been reviewed and approved by the signatory approver at the research office (or equivalent) in the host institution before it is submitted to the charity. Therefore, applicants should ensure that they give the signatory approver sufficient time before the scheme closing date to review the application and approve it. Please note that many host institutions specify internal deadlines for this procedure.

Applications selected by HRCI-member charities for endorsement will then be submitted to the HRB via the online Grant E-Management System (GEMS) GEMS will automatically close at the deadline – TBC (January 2022).


Contact the relevant HRCI-registered charity for information on their application and selection procedure. An FAQ document can be found at .


All charity enquiries/information on participating charities:

Dr Sarah Delaney at the HRCI
Email: sarah(at)
Tel: +353 1 4793234

Opening date
13:00 01-09-2021
Closing date
12:00 11-03-2022
Decision expected
June 2022